Drug Type Small molecule drug |
Synonyms |
Target |
Mechanism NTMT1 inhibitors(N-terminal Xaa-Pro-Lys N-methyltransferase 1 inhibitors), NTMT2 inhibitors(N-terminal Xaa-Pro-Lys N-methyltransferase 2 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC25H40N8O5 |
InChIKeyOTJOBCMTWIFWOC-UFYCRDLUSA-N |
CAS Registry2606862-05-7 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Neoplasms | Preclinical | US | 10 Sep 2020 |